These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35543272)

  • 41. Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets.
    Vogels CBF; Brito AF; Wyllie AL; Fauver JR; Ott IM; Kalinich CC; Petrone ME; Casanovas-Massana A; Catherine Muenker M; Moore AJ; Klein J; Lu P; Lu-Culligan A; Jiang X; Kim DJ; Kudo E; Mao T; Moriyama M; Oh JE; Park A; Silva J; Song E; Takahashi T; Taura M; Tokuyama M; Venkataraman A; Weizman OE; Wong P; Yang Y; Cheemarla NR; White EB; Lapidus S; Earnest R; Geng B; Vijayakumar P; Odio C; Fournier J; Bermejo S; Farhadian S; Dela Cruz CS; Iwasaki A; Ko AI; Landry ML; Foxman EF; Grubaugh ND
    Nat Microbiol; 2020 Oct; 5(10):1299-1305. PubMed ID: 32651556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterizing SARS-CoV-2 Transcription of Subgenomic and Genomic RNAs During Early Human Infection Using Multiplexed Droplet Digital Polymerase Chain Reaction.
    Hwang HS; Lo CM; Murphy M; Grudda T; Gallagher N; Luo CH; Robinson ML; Mirza A; Conte M; Conte A; Zhou R; Vergara C; Brooke CB; Pekosz A; Mostafa HH; Manabe YC; Thio CL; Balagopal A
    J Infect Dis; 2023 Apr; 227(8):981-992. PubMed ID: 36468309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and epidemiologic characteristics of inconclusive results in SARS-CoV-2 RT-PCR assays.
    Lim YK; Kweon OJ; Kim HR; Kim TH; Lee MK
    BMC Infect Dis; 2021 Aug; 21(1):851. PubMed ID: 34418960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of coronavirus disease 2019 (COVID-19) pre-test probability on positive predictive value of high cycle threshold severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcription polymerase chain reaction (RT-PCR) test results.
    Gubbay JB; Rilkoff H; Kristjanson HL; Forbes JD; Murti M; Eshaghi A; Broukhanski G; Corbeil A; Fittipaldi N; Hopkins JP; Kristjanson E; Kus JV; Macdonald L; Majury A; Mallo GV; Mazzulli T; Melano RG; Olsha R; Perusini SJ; Tran V; Allen VG; Patel SN
    Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1179-1183. PubMed ID: 34369325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Open-source real-time quantitative RT-PCR-based on a RNA standard for the assessment of SARS-CoV-2 viral load.
    Comerlato J; Comerlato CB; Sant'Anna FH; Bessel M; Abreu CM; Wendland EM
    Mem Inst Oswaldo Cruz; 2022; 116():e210237. PubMed ID: 35107520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detectable Duration of Viable SARS-CoV-2, Total and Subgenomic SARS-CoV-2 RNA in Noncritically Ill COVID-19 Patients: a Prospective Cohort Study.
    Phuphuakrat A; Pasomsub E; Srichatrapimuk S; Kirdlarp S; Suksatu A; Srisaowakarn C; Manopwisedjaroen S; Ludowyke N; Purwono PB; Priengprom T; Wongsa A; Thakkinstian A; Hongeng S; Malathum K; Thitithanyanont A; Tassaneetrithep B
    Microbiol Spectr; 2022 Jun; 10(3):e0050322. PubMed ID: 35604133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of Primer-Probe Sets among Different Master Mixes for Laboratory Screening of Severe Acute Respiratory Syndrome Coronavirus 2 (
    Cuong HQ; Hai ND; Linh HT; Anh NH; Hieu NT; Thang CM; Thao NTT; Lan PT
    Biomed Res Int; 2020; 2020():7610678. PubMed ID: 33029522
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serological evaluation of patients with coronavirus disease-2019 in Daegu, South Korea.
    Park S; Chang SH; Lee JH; Lee JH; Ham JY; Kim YK; Kim SG; Ryoo NH
    PLoS One; 2022; 17(1):e0262820. PubMed ID: 35051239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection and Quantification of SARS-CoV-2 by Real-Time RT-PCR Assay.
    Wilhelm A; Pallas C; Marschalek R; Widera M
    Methods Mol Biol; 2022; 2452():75-98. PubMed ID: 35554902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Value of Viral Nucleic Acid in Sputum and Feces and Specific IgM/IgG in Serum for the Diagnosis of Coronavirus Disease 2019.
    He Y; Luo J; Yang J; Song J; Wei L; Ma W
    Front Cell Infect Microbiol; 2020; 10():445. PubMed ID: 32850506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. One-step quantitative RT-PCR assay with armored RNA controls for detection of SARS-CoV-2.
    Goncharova EA; Dedkov VG; Dolgova AS; Kassirov IS; Safonova MV; Voytsekhovskaya Y; Totolian AA
    J Med Virol; 2021 Mar; 93(3):1694-1701. PubMed ID: 32966645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated
    Chan JF; Yip CC; To KK; Tang TH; Wong SC; Leung KH; Fung AY; Ng AC; Zou Z; Tsoi HW; Choi GK; Tam AR; Cheng VC; Chan KH; Tsang OT; Yuen KY
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32132196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors associated with weak positive SARS-CoV-2 diagnosis by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR).
    Rawat P; Zerbato JM; Rhodes A; Chiu C; Tran T; Rasmussen TA; Druce J; Lewin SR; Roche M
    Pathology; 2022 Aug; 54(5):623-628. PubMed ID: 35778288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].
    Erensoy S
    Mikrobiyol Bul; 2020 Jul; 54(3):497-509. PubMed ID: 32755524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit.
    Krüttgen A; Cornelissen CG; Dreher M; Hornef MW; Imöhl M; Kleines M
    J Virol Methods; 2021 Feb; 288():114024. PubMed ID: 33227341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of In Situ Hybridization, Immunohistochemistry, and Reverse Transcription-Droplet Digital Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Testing in Tissue.
    Roden AC; Vrana JA; Koepplin JW; Hudson AE; Norgan AP; Jenkinson G; Yamaoka S; Ebihara H; Monroe R; Szabolcs MJ; Majumdar R; Moyer AM; García JJ; Kipp BR
    Arch Pathol Lab Med; 2021 Jul; 145(7):785-796. PubMed ID: 33720333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel automated sample-to-result SARS-CoV-2 laboratory-developed RT-PCR assay for high-throughput testing using LabTurbo AIO 48 system.
    Jian MJ; Chung HY; Chang CK; Lin JC; Yeh KM; Chiu SK; Wang YH; Liao SJ; Li SY; Hsieh SS; Perng CL; Chang FY; Shang HS
    Clin Chim Acta; 2021 Mar; 514():54-58. PubMed ID: 33316217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sars-Cov-2 Infection Screening Using Two Serological Testing Methods.
    Arinola OG; Edem VF; Rahamon SK; Yaqub SA; Fashina AO; Alonge TO
    Niger J Physiol Sci; 2020 Dec; 35(2):117-121. PubMed ID: 34009193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.
    Laverack M; Tallmadge RL; Venugopalan R; Cronk B; Zhang X; Rauh R; Saunders A; Nelson WM; Plocharczyk E; Diel DG
    Arch Virol; 2021 Sep; 166(9):2551-2561. PubMed ID: 34259914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid Serological Assays and SARS-CoV-2 Real-Time Polymerase Chain Reaction Assays for the Detection of SARS-CoV-2: Comparative Study.
    Paradiso AV; De Summa S; Loconsole D; Procacci V; Sallustio A; Centrone F; Silvestris N; Cafagna V; De Palma G; Tufaro A; Garrisi VM; Chironna M
    J Med Internet Res; 2020 Oct; 22(10):e19152. PubMed ID: 33031048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.